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ABSTRACT 
 
Molecular Mechanism of Ferricsiderophore Transport via the Outer Membrane Receptor  
FhuA in Escherichia coli 
 
by 
Jennifer K Cooke 
 
 
Iron is essential for life and growth in most organisms. Although it is abundant, iron 
exists mostly as insoluble iron-oxyhydroxide. Bacteria secrete siderophores to chelate 
iron and transport it into the cell via specific outer membrane receptors. The FhuA 
receptor protein transports ferrichrome, a siderophore produced by Ustilago 
sphaerogena. We determined the binding affinity of variants from the conserved ‘lock 
region’ of FhuA and also created and characterized variants of the highly conserved 
R452 to determine its role in ferrichrome transport. We hypothesize that during transport 
the plug domain of FhuA does not leave the barrel; rather it undergoes a conformational 
change to form a channel. We mutated selected amino acids to cysteine to form 
disulfide bonds to tether the plug, preventing its displacement or unfolding during 
transport. The tetra-cysteine mutant 72/615/109/356C was able to bind and transport 
radiolabeled ferrichrome. One double-cysteine mutant, 104/149C, was purified for 
crystallization. 
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CHAPTER 1 
INTRODUCTION 
 
The Importance of Iron 
Iron is the 26th element in the periodic table and has a formula weight of 55.85. It 
is the fourth most abundant element in the earth’s crust, following oxygen, silicon, and 
aluminum (Hem 1959). Most of the earth’s core is made up of metallic iron. Iron readily 
participates in chemical oxidation and reduction reactions and forms both organic and 
inorganic complexes that affect its solubility (Hem 1959). 
 In the environment, iron commonly occurs in igneous, metamorphic, and 
sedimentary rocks and in soil. In sedimentary rocks, ferric iron (Fe+3) is more abundant, 
whereas ferrous iron (Fe+2) exists more often in igneous and metamorphic rocks (Hem 
1959).  Weathering of these rocks at a neutral pH in aerobic conditions oxidizes most 
ferrous iron, converting it to the ferric state. Ferric iron is then incorporated into clay 
minerals or hydrolyzed to ferric oxyhydroxides such as goethite (α-FeOOH), akaganeite 
(β-FeOOH), and lepidocrocite (γ-FeOOH) (Oades 1963). In soil, iron exists primarily in 
the ferric state, although ferrous iron may be more abundant in soils that are rich in 
organic matter.  Ferric oxyhydroxides are the most common iron-containing compounds, 
especially amorphous oxyhydroxide, goethite, and hematite (Oades 1963). 
 Iron can be found in all living organisms and is essential for many biological 
processes including ATP synthesis, electron transport, and the reduction of DNA 
precursors (Litwin and Calderwood 1993). Bacteria require an internal iron 
concentration of 1µM or higher in order to support growth and reproduction (Raymond 
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et al. 2003). However, the free ferric iron concentration in equilibrium with environmental 
ferric oxyhydroxide is approximately 10-17 M, far below what bacteria need in order to 
persist (Raymond et al. 2003). Iron acquisition is an important virulence factor during 
bacterial infection. Bacteria have developed several efficient mechanisms to overcome 
the problem of iron availability. One of these systems involves the secretion of small 
organic molecules known as siderophores (Braun et al. 1999; Braun and Braun 2002). 
 
Siderophores 
Siderophores (Greek for “iron carrier”) are small molecules produced by bacteria 
and fungi that chelate ferric iron from the environment with high affinity and transport it 
into the cell using an energy-dependent transport system (van der Helm et al. 1987). 
They have a molecular weight ranging from 500-1500 Da. Many are nonribosomal 
peptides from a class of secondary peptide metabolites produced by bacteria and fungi 
that are typically synthesized independently of mRNA by nonribosomal peptide 
synthetases (Ecker et al. 1986). One of their defining characteristics is their charge; 
after chelation of iron, they have a net charge of -3. Despite the incredible diversity in 
their structures, most siderophores can be classified as either catecholate or 
hydroxamate types, based on whether they use a catechol or a hydroxamate group to 
chelate iron. Enterobactin (Fig. 1), which is produced by Escherichia coli, is an example 
of a catechol type siderophore (Ecker et al. 1986). Ferrichrome (Fig. 1), which is 
produced by the fungus Ustilago sphaerogena, is an example of a hydroxamate type 
siderophore (van der Helm et al. 1980). Siderophores have also been reported with 
carboxylate groups or mixed groups such as schizokinen, pseudobactin, and 
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pyoverdine (Cobessi et al. 2005; Storey et al. 2006). It is not uncommon for bacteria or 
fungi to produce more than one type of siderophore and the same type of siderophore 
may be produced by more than one species.   
 
 
A. Enterobactin     B. Ferrichrome 
Figure 1  Examples of typical siderophores: A. Enterobactin is an example of a catechol 
type siderophore; B. Ferrichrome is a hydroxamate siderophore 
 
Siderophore Transport 
 
Outer Membrane Transporter Proteins 
In Gram negative bacteria, iron transport is achieved via the binding of the 
ferricsiderophore complex to proteins in the outer membrane that function as 
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transporters (van der Helm 1998). Protein sequences have been reported for more than 
30 such outer membrane proteins transporting chemically diverse ferricsiderophores 
(van der Helm 1998, van der Helm and Chakraborty 2002 and references therein). The 
binding sites of ferricsiderophore outer membrane transporters are known to be highly 
selective for only one siderophore (Schalk 2007). After binding to the transport protein, 
the ferricsiderophore is released from the binding site and vectorally transported across 
the outer membrane into the periplasm (Braun and Braun 2002). Multiple alignment 
studies on 19 different iron transport proteins have shown 20% similarity or greater 
when the protein sequences are aligned. In cases where they transport the same 
siderophore (e.g., FepA, BfeA, and PfeA which all transport ferricenterobactin), the 
similarity is approximately 40% (Chakraborty et al. 2003 and references therein). 
The crystal structures of the outer membrane ferricsiderophore transport proteins 
FecA, FepA, and FhuA from Escherichia coli and FpvA and FptA from Pseudomonas 
aeruginosa have been solved (Ferguson et al. 1998; Locher et al. 1998; Buchanan et al. 
1999; Ferguson et al. 2002; Cobessi et al. 2005). FhuA, FecA, FpvA, and FptA have 
also been solved in their ligand-bound forms (Ferguson et al. 1998; Locher et al. 1998; 
Ferguson et al. 2002; Cobessi et al. 2005). The structures of these proteins are very 
similar (Fig. 2); they consist of a 22 strand β-barrel composed of approximately 600 C-
terminal residues and a plug domain formed inside the barrel of approximately 150 N-
terminal residues (Chakraborty, et al. 2006 and references therein). All ferricsiderophore 
outer membrane receptor proteins have 8-10 conserved residues in their N-terminus 
known as the ‘TonB box’, which interacts in the periplasm with the C-terminus of TonB 
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at the glutamine at location 160 in the protein sequence (Lundrigan and Kadner 1986; 
Sauer et al. 1990; Howard et al. 2001).  
 
 
 
 
 
 
Figure 2  Space-filled model of the outer membrane receptor protein FepA as viewed 
from the periplasm. The blue area represents the plug domain blocking access from the 
extracellular medium (Chakraborty et al. 2006, used with permission). 
 
The TonB-ExbB-ExbD Complex 
 Transport across the outer membrane is an energy-consuming process that 
requires the transport protein to interact with the TonB-ExbB-ExbD complex to provide 
the necessary proton motive force (Wandersman and Delepelaire 2004 and references 
therein). The TonB-ExbB-ExbD complex can be found in all siderophore-mediated iron 
transport systems in Gram negative bacteria. It also plays an important role in other 
non-siderophore types of iron transport such as the heme transport system 
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(Wandersman and Delepelaire 2004). In E. coli, TonB-dependent receptors also 
transport vitamin B12 and other nutrients that are too large, too scarce, and too 
important to diffuse across the outer membrane through porin proteins (Devanathan and 
Postle 2007).  
TonB can be divided into three domains. Residues 1-33 form the amino terminal 
domain and are anchored to the inner membrane to serve as the site of interaction with 
ExbB-ExbD. Residues 34-154 form the central domain with repeating Pro-Glu and Pro-
Lys located in the periplasm, and residues 155-239 form the carboxy-terminal domain, 
which is also located in the periplasm (Chakraborty et al. 2006). Residues 155-239 
interact with the N-terminus of ferricsiderophore receptors in the outer membrane 
(Wiener 2005). Under iron-limiting conditions, TonB expression is increased (Wiener 
2005 and references therein).  
TonB-dependent energy transduction requires interactions with two additional 
proteins, ExbB and ExbD (Postle and Kadner 2003). ExbB is a cytoplasmic membrane 
protein (~26 kDA) with a periplasmic N-terminus. It is composed of a cytoplasmic 
domain consisting of approximately 90 residues and two transmembrane domains 
(Postle and Kadner 2003). ExbD is a cytoplasmic membrane protein with an identical 
topology to TonB and a periplasmic domain of approximately 90 residues (Postle and 
Kadner 2003). ExbB and ExbD are homologues of MotA and MotB proteins of the 
bacterial flagellar motor, and they energize TonB by coupling with the proton motive 
force of the cytoplasmic membrane (Braun and Braun 2002; Chakraborty et al. 2006). In 
the absence of any interactions between the TonB complex and the TonB box, ligands 
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like siderophores continue to bind to transport proteins with high affinity but are not 
transported across the outer membrane (Devanathan and Postle 2007). A requirement 
for ATP hydrolysis would be consistent with the participation of an additional 
undiscovered protein in the TonB system (Postle and Larsen 2004). It has been shown 
that TonB activity decreases rapidly in the presence of protein synthesis inhibitors. 
Chromosomally encoded TonB, ExbB, and ExbD have all been shown to be stable in 
the presence of these inhibitors, indicating the existence of one or more different short-
lived protein(s) in the system (Postle and Larsen 2004 and references therein). It is 
possible that the short half-life of TonB activity under these conditions is indicative of the 
contribution of one or more as yet uncharacterized proteins.  
Efforts to isolate and purify the whole TonB protein have been unsuccessful due 
to its instability, but the structure of the C-terminus has been solved in complex with 
FhuA and BtuB (Pawelek et al. 2006; Shultis et al. 2006). In both structures, the C-
terminus is replaced by the TonB box of the receptor protein in the beta sheet, but this 
interaction does not result in any conformational change of the outer membrane 
receptor beyond those directly involved in the movement of the TonB box (Chakraborty 
et al. 2006). The mechanism by which TonB transduces energy to the outer membrane 
receptor protein is not well understood and is still a subject of investigation. 
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Periplasmic Binding Proteins 
 Once it enters the periplasm, the ferricsiderophore complex must make its way to 
an ABC (ATP binding cassette) transporter protein in order to cross the cytoplasmic 
membrane. Because these membrane proteins do not necessarily have a strong 
binding affinity for the substances they transport, Gram negative bacteria use a number 
of soluble periplasmic binding proteins (PBPs) (Koster 2001; Borths et al. 2002). PBPs 
act as high-affinity carriers that bind and escort nutrients to the membrane transporters 
so they may be taken into the cytoplasm of the cell. They are usually required for 
nutrient uptake and may also be involved in chemotaxis and energy transduction 
(Berendsen and Hayward 2000).  PBPs are homologous to many eukaryotic receptors 
including the glutamate-gated ion channel (NMDA) receptors, binding domains from G-
protein-coupled receptors (GPCRs), and guanylate cyclase-atrial natriuretic peptide 
(ANP) receptors (Bruns et al. 1997).  
PBPs are bilobal, with the lobes joined either by 2-3 β-strands or by a long 
backbone helix. Each lobe has a mixed αβ structure (Duan et al. 2001; Lee et al. 2002). 
FhuD is the only periplasmic siderophore binding protein (PSBP) to have its structure 
reported and is used as a model to understand the mechanism of siderophore binding 
(Clarke et al. 2000). FhuD has a resemblance to ExbD and binds a variety of 
hydroxamate siderophores: ferrichrome, coprogen, ferrioxamine B, and rhodotorulic 
acid (Clarke et al. 2002). The structure of gallichrome-bound FhuD had also been 
solved (Clarke et al. 2000). Gallichrome was used instead of ferrichrome to reveal a 
lesser degree of specificity in FhuD that allows it to bind to a number of hydroxamate-
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type siderophores. Only 45% of the molecular surface of gallichrome is buried in the 
complex, bound by four hydrogen bonds (Clarke et al. 2000). The interactions between 
FhuA and FhuD that result in acquisition of the ferricsiderophore complex from the outer 
membrane transporter are not well understood. It is possible that FhuD may simply bind 
to the ferricsiderophore in the periplasm after it has been released from the transporter 
(Clarke et al. 2000). 
 
ABC Transporter Proteins 
 For iron to be released into the cytoplasm, a specific ABC transporter able to 
bind the ferricsiderophore is required for passage across the inner membrane (Fig. 3). 
In E. coli, the transporters involved in this process are FhuBCD for ferrichrome and 
FepBCD for ferricenterobactin (Koster 2001). FhuD, as previously discussed, is a PBP 
that binds to the ferricsiderophore and escorts it to the cytoplasmic membrane. FhuB is 
located in the cytoplasmic membrane, and FhuC (an ATPase) is associated with the 
inside of the cytoplasmic membrane. Peptide-mapping studies have shown that the 
FhuD-ferricsiderophore complex interacts with the transmembrane region and 
cytoplasmic segment 7 of FhuB (Braun et al. 2004 and references therein). A negatively 
charged Glu111 and Asp225 on the apex of each lobe of FhuD may contact with 
positively charged arginine pockets of FhuB, causing the transmembrane region of 
FhuB to form a pore through which FhuD inserts itself and transfers the 
ferricsiderophore to the cytoplasm in a process driven by ATP hydrolysis from FhuC 
(Locher et al. 2002; Mademidis et al. 1997). 
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Figure 3  A summary of the iron uptake process in gram-negative bacteria 
(Unpublished, used with permission). 
 
The Fate of Ferricsiderophore Complexes Inside the Cell 
 Once it reaches the cytoplasm, the ferricsiderophore complex dissociates. Two 
mechanisms for the release of iron from the ferricsiderophore complex have been 
described in Gram negative bacteria. The first involves hydrolysis of the complex, such 
as the degradation of ferricenterobactin in E. coli, in which the cyclic triester is 
hydrolyzed by esterases (Langman et al. 1972). The second involves the reduction of 
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ferric iron to ferrous iron, which has a much lower affinity for the siderophore. The 
siderophore may then be recycled to the extracellular medium (Matzanke et al. 2004 
and references therein). This is the mechanism described in E.coli for ferrichrome, 
coprogen, and ferrioxamine B (Matzanke et al. 2004). Iron that will not be used 
immediately is taken up by bacterial iron storage proteins.  
Bacteria possess two types of iron-storage protein, the heme-containing 
bacterioferritins and heme-free ferritins (Andrews 1998). Bacterioferritins and ferritins 
are not closely related but have shown similar structural and functional properties. Both 
are composed of 24 identical subunits that form a spherical complex with a large hollow 
center (Bruns et al. 1997; Andrews 1998). The hollow center acts as an iron-storage 
cavity with the capacity to accommodate at least 2000 iron atoms in the form of a ferric-
hydroxyphosphate complex. The role of the heme is unknown, although it may be 
involved in mediating iron-core reduction and iron release (Andrews 1998). Some 
bacteria contain two bacterioferritin subunits, or two ferritin subunits, while others have 
both a bacterioferritin and a ferritin, and some show no evidence that they possess any 
type of iron-storage protein (Andrews 1998 and references therein). The reason for 
these differences is not understood. Studies on ferritin mutants have shown that ferritin 
facilitates growth during iron starvation and is also involved in iron accumulation during 
the stationary phase of growth.  
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Regulation of Ferricsiderophore Transport Systems 
 If intracellular iron concentration is sufficient, bacteria shut off the synthesis of 
siderophores and transport proteins by inhibiting the transcription of the related genes 
via binding of ferrous iron to two proteins: Fur and DtxR, which act in the iron-loaded 
form as transcriptional repressors (Hantke and Braun 2000). The Fur protein of E. coli is 
a 17 kDa DNA-binding protein that interacts with target sequences of the genome based 
on the presence or absence of intracellular ferrous iron. Fur is an abundant protein, with 
approximately 5,000 copies per cell during the logarithmic growth phase and 10,000 
copies during stationary phase (de Lorenzo et al. 2004 and references therein). It has 
been estimated that more than 90 genes in E. coli are regulated by Fur (de Lorenzo et 
al. 2004 and references therein). Fur is capable of polymerizing along the target strand 
of DNA, which may strengthen the repressive signal (de Lorenzo et al. 2004). Fur may 
also function as a storage protein for free ferrous iron, protecting the cell from redox 
damage (de Lorenzo et al. 2004). Fur target sites, also known as the Fur box, are highly 
conserved in many bacteria (Wee et al. 1988; de Lorenzo et al. 1988). The Fur box 
consists of a 19 bp inverted, AT-rich sequence. The mechanism of Fur binding is not 
entirely understood; the existence of the Fur box coupled with the dimeric structure of 
the protein seem to suggest that Fur interacts with DNA in the manner of classical 
bacterial repressors, which a protein dimer recognizes and binds to a palindromic 
sequence (de Lorenzo et al. 1988). However, more recent studies indicate that multiple 
Fur molecules wrap around the DNA helix in a screw-like manner, extending into 
regions that do not appear to match the Fur box (de Lorenzo et al. 2004).  
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Other Systems for Iron Acquisition in Bacteria 
 Siderophore acquisition systems are not the only mechanism employed by 
bacteria to gain iron. Many Gram negative bacteria also use the Feo system, which 
transports ferrous iron and is typically active under anaerobic conditions (Kammler et al. 
1993). Heme is also used as a potential iron source. Some organisms are able to bind 
heme directly and transport it across the membrane via a TonB-dependent mechanism. 
In Shigella, ShuA is the receptor for heme (ChuA in E. coli) (Burkhard and Wilks 2007) 
and these receptors appear to share some similarity with ferricsiderophore transporters 
(Wandersman and Stojiljkovic 2000). Once inside the cell, iron is extracted from heme 
by heme oxygenases that break the tetrapyrrole ring (Debarbieux and Wandersman 
2004).  
 Bacteria may also secrete hemophores that chelate iron from a variety of 
sources. The hemophore HxuA has been identified in Haemophilus influenza (Cope et 
al. 1995). HxuA is secreted by a signal peptide-dependent pathway. It acquires heme 
from hemopexin and presents it to the HxuC receptor in the outer membrane (Cope et 
al. 1995; Cope et al. 2001). Another hemophore system has been described in several 
bacteria including Serratia marcescens, Pseudomonas aeruginosa, Pseudomonas 
fluorescens, and Yersinia pestis. These hemophores, called HasA (“heme acquisition 
system”), do not demonstrate homology to any other known proteins (Letoffe et al. 
1994; Letoffe et al. 1998; Debarbiex and Wandersman 2004). HasA hemophores are 
secreted by ABC transporters and require the SecB chaperone for efficient secretion 
(Arnoux et al. 1999).  
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Iron as a Virulence Factor 
 Thanks to the evolution of hemoglobin for oxygen transport, the required 
concentration of iron in vertebrates is three times that of lower life forms (Bothwell and 
Finch 1962). However, most of this iron is sequestered away by storage and transport 
proteins like transferrin and lactoferrin. The ability to sequester iron in these storage 
proteins is a primary defense mechanism against bacterial infection. To establish a 
successful infection, bacterial pathogens must overcome host iron limitation (Braun and 
Braun 2002). This selective pressure has led to the development of iron uptake systems 
specific to host iron sources such as heme and transferrin (Bullen and Griffiths 1999). 
These mechanisms can take the form of specific receptors or siderophores that are 
capable of removing iron from human transferrin (Bullen and Griffiths 1999). Transferrin 
iron accounts for less than 1% of the human body’s total iron, while heme iron accounts 
for more than 80%. The abundance of heme iron over other sources may provide a 
favorable environment for pathogens such as Staphylococcus aureus that preferentially 
acquire iron from heme (Skaar et al. 2004). Other indications that iron can play a role in 
virulence are demonstrated by the fact that several virulence factors are iron-regulated. 
For example, shiga toxin (Shigella), shiga-like toxin (enterohemorrhagic E. coli), 
diphtheria toxin (C. diphtheriae), and exotoxin A (Pseudomonas aeruginosa) are 
regulated directly by iron concentration or by an iron-responsive regulator (Litwin and 
Calderwood 1993). Additionally, the genes for hemophore expression in E. coli are 
located on the pColV virulence plasmid, suggesting that it may have a role in virulence 
(Otto et al. 1998). 
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 Surprisingly, some bacterial pathogens have overcome this host defense 
mechanism by eliminating the need for iron. Analysis of the membranes of Borrelia 
burgdorferi indicated a lack of any metalloproteins commonly found in bacterial 
membranes (Bledsoe et al. 1994). Analysis of the complete genome sequence 
confirmed that B. burgdoferi does not possess genes encoding these proteins (Fraser et 
al. 1997). Even the Fur homolog of B. burgdorferi does not appear to require iron as a 
cofactor; it has shown a 54.3% similarity to the Bacillus subtilis perR gene product that 
uses manganese as a cofactor (Bsat et al. 1998 and references therein). The B. 
burgdoferi SodA has demonstrated >50% identity with manganese-dependent enzymes 
from Thermus thermophilus, Thermus aquaticus, and Bordetella pertussis (Graeff-
Wohlleben et al. 1997 and references therein). Therefore, B. burgdorferi may be 
manganese-dependent rather than iron-dependent. The intracellular iron concentration 
in B. burgdorferi has been shown to be less than 10 atoms per cell, well below any 
physiologically relevant concentration (Posey and Gherardini 2000). 
  
Other Applications for the Study of Iron Transport Systems 
 The study of iron acquisition systems in bacteria has many potential benefits. 
There is a growing threat of antibiotic resistance in many dangerous pathogens, most 
notably in Methicillin-Resistant Staphylococcus aureus (MRSA) and Mycobacterium 
tuberculosis. Siderophore-mediated iron transport systems present an intriguing new 
target for antibiotics. A significant decrease in virulence has been demonstrated in 
uropathogenic E. coli double mutants unable to synthesize the outer membrane 
25 
 
receptor proteins FepA and IutA when introduced into the mouse kidney (Torres et al. 
2001), because of the organisms’ decreased ability to transport iron. This suggests that 
therapeutic agents that target outer membrane receptors may be an effective way to 
treat bacterial infection. It is also notable that some outer membrane siderophore 
receptor proteins also transport antibiotics (Braun and Braun 2002 and references 
therein). This dual function may be useful in bypassing some antibiotic resistance 
mechanisms by conjugating antibiotics with low diffusion rates to ferricsiderophore 
complexes (Braun and Braun 2002). Another potential target is siderophore 
biosynthesis. In 2005 Ferreras et al. identified a small molecule called salicyl-AMS that 
inhibits siderophore biosynthesis and, subsequently, growth of M. tuberculosis and Y. 
pestis in vitro (Ferreras et al. 2005). A synthetically designed nucleoside antibiotic has 
recently been shown to inhibit siderophore biosynthesis in M. tuberculosis by inhibiting 
the activity of the adenylate-forming enzyme MbtA that is involved in the secretion of 
mycobactins (Somu et al. 2006). 
 The study of iron transport may also yield more options for the treatment of 
diseases associated with iron overload. The most popular treatment currently in use is 
Desferal, a synthetic siderophore of the ferrichrome family (Hussein et al. 1976). 
Desferal chelates excess iron and is an effective agent in the treatment of patients with 
iron poisoning or β-thalassemia, a condition in which patients produce defective 
hemoglobin and must undergo periodic blood transfusions, leading to an accumulation 
of iron in the body (Hussein et al. 1976). This therapy can be cost-prohibitive and is only 
available by injection, requiring patients to follow a strict regimen (Cao et al. 1997). It is 
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possible that a greater understanding of siderophores and siderophore transport might 
yield less costly iron-chelating treatments with a more efficient system of delivery.  
  
FhuA 
FhuA transports ferrichrome and also serves as a transporter for the antibiotics 
albomycin, rifamycin CGP 4832, and microcin J25 and as a receptor for colicin M and 
bacteriophages T1, T5, and Φ80 (Ecker et al. 1986; Braun and Braun 2002). Residues 
6-11 serve as the TonB box (Braun and Braun 2002). The crystal structures of the 
protein appear to show that transport from the binding site to the periplasm requires 
either a major conformational change in the plug domain or complete dislodgement of 
the plug to allow the siderophore complex to move through the barrel (Chakraborty et al. 
2003). It is thought that ligand-induced movement of the N-proximal region of FhuA 
facilitates its interaction with the TonB protein (Braun and Braun 2002). Interaction with 
TonB opens a channel in the β-barrel, turning FhuA into a porin-like protein that allows 
the ferricsiderophore complex to diffuse into the periplasm. Ferrichrome may diffuse 
along amino acid side chains that line the channel, as has been shown for the facilitated 
transport of maltodextrins through the LamB porin (Van Gelder et al. 2002). It is less 
likely that the entire plug domain is removed from the channel to allow transport, 
because this would require significantly more energy (Braun et al. 1998), and there are 
more than 60 hydrogen bonds involved in binding the plug to the β-barrel (Braun and 
Braun 2002).  
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Conserved Regions in FhuA 
Certain amino acid residues, which are highly conserved in the family of ferric 
siderophore transporting outer membrane receptors, have been shown to have an 
important purpose during the internalization of ferricsiderophore complexes 
(Chakraborty et al. 2003). One such interesting residue is the arginine located on beta 
strand 11 in all ferricsiderophore receptors (Lopez et al. 2007). This arginine is 
conserved in all ferricsiderophore transporters and also among heme transporters. In 
FatA, it has been shown that mutation of this arginine to alanine reduces transport 
without affecting receptor binding (Lopez et al. 2007). If arginine 452 has a common role 
in the transport of ferricsiderophore complexes into the cell, its mutation to alanine or 
glutamine in FhuA should show similar results. There are several conserved regions 
and amino acid residues that have been identified and mutated in the ferricenterobactin 
transporter FepA such as Gly127, Arg75, and Glu567 (Chakraborty et al. 2003). In the 
N-terminal and beta barrel domains of FepA, there is a ‘lock region’ that includes a 
cluster of 10 highly conserved amino acids.  There is a central component made up of 
four charged residues: Arg75, Arg126, Glu 511, and Glu567 (Chakraborty et al. 2003). 
These four residues form hydrogen bonds with other amino acids in the lock region that 
may play an important role in maintaining its structural integrity (Chakraborty et al. 
2003).The center of this cluster connects to two arginines from the plug and two 
glutamates from the barrel, forming a quadrupole. This lock region is structurally the 
same in FepA, FhuA, and FecA (Fig. 4) (Buchanan et al. 1999; Ferguson et al. 2002; 
Chakraborty et al. 2003). It is possible that the binding of ferrichrome to the receptor, 
followed by its interaction with TonB, induces a conformational change in the lock region 
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leading to channel formation. It has been shown that the mutation of conserved 
residues from this region, both in FepA and FhuA, selectively affects the transport 
without affecting binding. In FhuA, Glu522Gln, Glu522Arg, Glu571Gln, Glu571Arg, 
Gly141Arg, and Arg93/133Gln (Fig. 5) have all been identified as mutants that show 
defective transport and normal binding (Chakraborty et al. 2006).   
 
Figure 4  Structural configuration of the conserved residues of the ‘lock region’ in three 
outer membrane receptors in E. coli (Chakraborty et al. 2006, used with permission). 
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Figure 5  Locations of some residues of interest in FhuA (Unpublished, used with 
permission). 
 
Conformational Changes During Transport 
 As previously discussed, the plug domain of FhuA is held in position inside the β-
barrel by approximately 60 hydrogen bonds (Chakraborty et al. 2006). Analysis of the 
ligand-bound structures of FhuA and FecA and the recently solved structures of FpvA 
and FptA have shown that the binding of the ferricsiderophore induces conformational 
changes in the extracellular loops, barrel, and in the plug, but it does not induce the 
formation of any pore large enough for the ferricsiderophore to pass through 
(Chakraborty et al. 2006). In order for this to occur, the plug would either have to be 
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dislodged from the barrel, or it would have to undergo conformational changes within 
the barrel to form a channel. Dislodgement of the plug would explain the transport of 
larger molecules like colicin, but due to the abundance of intramolecular polar contacts 
between the surfaces of the plug and β-barrel, this scenario does not present an 
efficient use of energy (Chakraborty et al. 2006). Recent studies have also indicated 
that colicin may use the outer membrane receptor protein as a binding site and then 
enter via a nearby porin (Kurisu et al. 2003). 
 
Present Work 
Experiments were designed to show whether during transport of the siderophore 
the N-terminal plug domain is dislodged or if it remains in the barrel and goes through a 
conformational change that either forms a channel or causes the plug domain to 
partially unfold. Double- and quadruple-cysteine mutants were created to either tether 
the plug or prevent its unfolding. Nonconserved residues at locations 72, 109, 356, and 
615 in the plug and beta barrel were mutated to cysteine in order to tether the plug in 
place so that it could not be dislodged during transport. By using nonconserved 
residues, any deleterious effects on iron transport that might result from mutating an 
amino acid that is essential to the structure and function of the protein can likely be 
avoided. Another cysteine mutant, 104/149Cys (Fig. 6), had been previously created by 
graduate student Erin Storey with a disulfide bridge connecting two strands within the 
plug to prevent its unfolding. This variant FhuA has shown normal binding with 
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completely diminished transport, and was purified using high performance liquid 
chromatography (HPLC) for crystallization so that its structure can be determined.   
In addition, the KD and KM were determined for mutants R93A, E571A, E571Q, 
E522/571A, E522/571Q, and R133A that were previously created by Chakraborty et al. 
but had not been characterized. These values were compared to those of the wild type 
to determine if any of these mutants are defective in binding. Site-directed mutagenesis 
was used to mutate the arginine 452 to alanine and glutamine. There are two reasons 
why FhuA was chosen as a model for this project. First, the crystal structure of FhuA is 
available both in native form and bound with ferrichrome (Ferguson et al. 1998; Locher 
et al. 1998). Second, ferrichrome is a very stable siderophore and is therefore easy to 
handle and can be used for co-crystallization with FhuA. 
 
Figure 6. The disulfide bridge created by the double-cysteine mutant 104/149C 
(Unpublished, used with permission). 
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CHAPTER 2 
MATERIALS AND METHODS 
 
Bacterial Cultures and Growth Conditions 
All materials and reagents, unless otherwise indicated, were purchased from 
Fisher Scientific. Mutations in the FhuA gene cloned in pAlter plasmid (Fig. 7) were 
carried out using E. coli JM109 cells. The open reading frames of variant FhuA were 
cloned into the plasmid pUC18 under the lac promoter and transformed into E. coli 
KDF541, which is genetically engineered to knock out all iron transporting systems 
(Rutz et al. 1992). Variants were grown in Luria-Bertani (LB) broth at pH 7.5. Ampicillin 
or Carbenicillin was added for a final concentration of 100 µg/ml. For plates, 15 g/L agar 
was added before autoclaving. Glycerol stock cultures of cells containing all wild type 
strains and variants were prepared and stored at -80˚C. Cultures were grown in LB 
broth with 100 µg/ml carbenicillin for 12-14 hours and used as inoculum in fresh media 
and allowed to grow to OD600 0.5-0.6 for the preparation of stock cells. Bacterial culture 
aliquots of 0.8 mL were added to 0.2 ml sterile 75% glycerol in 1.5 ml Eppendorf tubes 
and frozen at -80˚C.  
Because siderophores are only produced under iron-limiting conditions, MOPS 
minimal medium (Table 1) was used as an iron-restricted media. E. coli was grown in 
LB broth with 100 µg/ml carbenicillin on a rotary shaker at 37˚C for 12-14 hours prior to 
inoculating iron-restricted media. E. coli was grown in LB broth with 100 µg/ml 
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carbenicillin on a rotary shaker at 37˚C for 12-14 hours or until OD600= 0.4-0.6. Then, a 
1 µM concentration of 1 M IPTG was added, and the culture was returned to the shaker 
for 1.5-3 hours. Finally, the culture was removed from the shaker and could be used for 
further experimentation.  
Table 1  Formulas used in preparation of MOPS growth medium 
10X MOPS Buffer Concentrate 
 
250 mL 1 L 
1M MOPS, pH 7.4 100 mL 400 mL 
1M Tricine, pH 7.4 10 mL 40 mL 
0.01M FeSO4 2.5 mL 10 mL 
1.9M NH4Cl 12.5 mL 50 mL 
0.276M K2SO4 2.5 mL 10 mL 
0.0005M CaCl2 2.5 mL 10 mL 
0.528M MgCl2 2.5 mL 10 mL 
5M NaCl 25 mL 100 mL 
10X Micronutrient Solution 0.25 mL 1 mL 
ddH2O 90.75 mL 369 mL 
10X Micronutrient Solution (500 mL) 
3x10-6 M (NH4)6(Mo7)O24 18 mg 
4x10-4 M Boric Acid
 
123.5 mg 
3x10-5 M Cobalt Chloride 35.65 mg 
10-5 M Copper Sulfate 12.45 mg 
8x10-5 M Manganese Chloride 79.15 mg 
10-5 M Zinc Sulfate 14.35 mg 
ddH2O To 500 mL 
Complete MOPS Growth Medium (1 L) 
10X MOPS Concentrate 100 mL 
0.132 M K2HPO4 10 mL 
100% Glycerol 4 mL 
1% Proline/1% Leucine/1% 
Tryptophan/0.1% Thiamine Mix 
10 mL 
20% Casamino Acids 10 mL 
Sterile ddH2O 866 mL 
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Figure 7. FhuA genes were cloned into pAlter using the XbaI/Hind III site (© Promega 
Corporation USA, used with permission). 
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Synthesis of Variant FhuA 
 
Synthesis of Single-Stranded DNA 
 E. coli JM109 was grown to mid-logarithmic phase in LB broth (with 10 µg/ml 
Tetracycline) at 37°C. A 0.5 ml portion of this cul ture was used to inoculate 25 ml LB 
containing 10 µg/ml Tetracycline, which was then placed on a rotary shaker for 30 
minutes at 37°C. Next, the culture was infected wit h 0.2 ml R408 Helper Phage and 
shaken for 6 hours at 37°C. This was centrifuged at  12,000 x g for 15 minutes, after 
which the supernatant was harvested and placed in a fresh tube to centrifuge again for 
15 minutes. A total of 0.25 volume phage precipitation solution was added and the 
supernatant was left on ice for 1-16 hours and centrifuged for 15 minutes at 12,000 x g.  
The pellet was resuspended in 0.4 ml TE buffer (pH 8.0) and transferred to a 
microcentrifuge tube. A 0.4 ml aliquot of chloroform:isoamyl alcohol (24:1) was added 
and the solution was vortexed for 1 minute to mix, then centrifuged at 12,000 x g for 5 
minutes. The upper aqueous phase was transferred to a new tube to which additional 
Chloroform:isoamyl alcohol was added in the amount of 0.4 mL. This solution was 
vortexed for 1 minute and centrifuged at 12,000 x g for 5 minutes. Next, the aqueous 
phase was transferred to a new tube and the previous step was repeated until there 
was no longer any visible material from the lipid phase at the surface. The final aqueous 
phase was transferred to a fresh tube and 0.5 volume 7.5 M ammonium acetate and 2 
volumes 100% ethanol were added. This solution was mixed and incubated at -20°C for 
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30 minutes. After incubation, the solution was centrifuged at 12,000 x g for 5 minutes. 
The supernatant was removed and the pellet containing ssDNA was rinsed with ice-cold 
70% ethanol and dried in a vacuum. 
   
Site-Directed Mutagenesis 
Primers were designed to mutate specific codons. A 20-25 bp long sequence of 
the FhuA gene was used, with the target codon as close to the center as possible. Only 
the target codon did not match the wild type sequence. Reaction mixtures of primers, 
single-stranded DNA, a tetracycline resistance knockout strand, and an ampicillin 
resistance repair strand were made in microcentrifuge tubes according to the 
instructions in the Promega Site-Directed Mutagenesis Kit (Fig. 8). Reaction mixtures 
were heated to 75°C for 5 minutes and cooled to 45° C at room temperature, then to 22-
25°C on ice. Once the primers and the repair and kn ockout strands were annealed to 
the single-stranded DNA, the following components were added: 5 µl dH2O, 3 µl 10X 
Synthesis Buffer, 1 µl T4 DNA Polymerase, and 1µl T4 DNA Ligase to complete the 
synthesis of the mutant strand using the single-stranded DNA as a template. This 
solution was incubated at 37°C for 90 minutes to al low synthesis of the double-stranded 
variant plasmid. Ampicillin knockout primers and tetracycline repair primers were also 
included in the kit in order to aid in multiple rounds of mutagenesis by using alternating 
antibiotic resistance as an indicator of successful reactions. For this procedure, FhuA 
genes were cloned into pAlter using the Xbal/HindIII site (Fig. 7). Mutated plasmids 
were cloned into JM109 cells and grown on ampicillin plates. Next, colonies were 
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selected and grown overnight in LB broth so that plasmids could be harvested for 
sequencing. Plasmids were isolated in Qiagen mini-prep columns and sequenced at the 
molecular biology facility at University of Tennessee, Knoxville. 
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Figure 8. Schematic diagram of the Altered Sites II in vitro mutagenesis procedure using 
the pAlter vector (© Promega Corporation USA, used with permission). 
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Analysis of Variant Protein Expression 
 
Preparation of Samples for SDS-PAGE 
A 2 ml seed culture of the variant E. coli was used to inoculate 50 ml LB 
containing 100 µg/mL Carbenicillin. This culture was grown to mid-logarithmic phase 
(OD600=0.4-0.6) and induced with 1 µM IPTG for 2-3 hours. Cells were harvested by 
centrifugation at 12,000 x g for 2 minutes and the supernatant was discarded. Equal 
volumes of 2X protein gel loading buffer (Table 2) were added to whole cell pellets and 
the pellet was resuspended. Samples and markers were boiled for 5 minutes prior to 
loading. 
 
SDS-PAGE  
Separating gels were prepared according to Table 3. A 30% Bis-acrylamide 
solution (Bio-Rad) was used. Gel components were deaerated for 10-15 minutes before 
the addition of ammonium persulfate. The separating gel was pipetted into a BioRad 
gel-casting unit and allowed to polymerize for 30 minutes. The stacking gel was 
prepared (Table 3) and deaerated for 10 minutes prior to the addition of ammonium 
persulfate. This gel was layered on top of the polymerized separating gel and a comb 
was placed. The stacking gel was allowed to polymerize for 20 minutes, then comb was 
removed and the gel was inserted into a Bio-Rad Mini Trans-Blot Electrophoretic 
Transfer Cell system and the upper and lower chambers were filled with electrode buffer 
40 
 
(Table 2). Samples consisting of 10 µL homogenized protein were loaded onto the gel 
and the unit was connected to a power supply and run at 30 milliamps per gel for 
approximately 1 hour or until the dye front reached the bottom of the gel. Once the gel 
finished running, it was removed from the system. SDS-PAGE gels were stained in a 
1% Coomassie blue solution, destained in 30% methanol, and preserved. Alternatively, 
once gels were removed from the electrophoresis system, they could also be 
electroblotted onto membranes and probed with antibodies against FhuA to verify 
protein expression. 
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Table 2  Recipes for buffers and reagents for SDS-PAGE. 
4X Running Gel Buffer (1.5 M Tris-Cl, pH 8.8) 
Tris 36.3 g (Adjust pH to 8.8 with HCl) 
ddH2O To 200 mL 
4X Stacking Gel Buffer (0.5 M Tris-Cl pH 6.8) 
Tris 3.0 g (Adjust pH to 6.8 with HCl) 
ddH2O To 50 mL 
10% SDS 
SDS 50 g 
ddH2O To 500 mL 
10% Ammonium persulfate 
Ammonium persulfate 0.5 g 
ddH2O To 5.0 mL 
2X Sample Buffer 
Stacking Gel Buffer 2.5 mL 
10% SDS 4.0 mL 
Glycerol 2.0 mL 
2-mercaptoethanol 1.0 mL 
ddH2O To 10.0 mL 
Electrode Buffer (4 L) 
Tris 12 g 
Glycine 57.6 g 
10% SDS 40 mL 
ddH2O To 4 L 
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Table 3  Formulas used in preparing 10% SDS-PAGE gels. 
 
 
Western Blot 
 Western blots were performed using Millipore PVDF (polyvinylidene fluoride) 
membranes and a Bio-Rad Mini Trans-Blot Electrophoretic Transfer Cell system. SDS-
PAGE gels, Whatman #2 filter papers, PVDF membranes, and sponges were 
equilibriated in transfer buffer (Table 4) for 5-20 minutes prior to blotting. Then, the 
blotting chamber was assembled and the proteins were blotted at 25v for 4-16 hours at 
4°C.  
 After the blots were removed from the system, they were soaked in 3% BSA 
(bovine serum albumin) blocking buffer (Table 4) for 1 hour at room temperature to 
reduce nonspecific binding of the primary antibody. Next, the blot was placed in a 1:100 
solution of anti-FhuA antibody (ProSci) prepared from rabbit serum and diluted in 
blocking buffer for 3 hours at room temperature or overnight at 4°C. After incubation, the 
primary antibody was poured off, and the blot was washed five times in wash buffer 
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(Table 4) for 6 minutes per wash and rinsed briefly in plain tris-buffered saline (TBS) 
(Table 4). Then, the blot was incubated for 2 hours to overnight at 4˚C in a 1:5,000 
solution of Horseradish peroxidase (HRP)-conjugated goat anti-rabbit IgG (Jackson 
ImmunoResearch) diluted in blocking buffer. After incubation with the secondary 
antibody, the blot was washed in five 6-minute washes with wash buffer and rinsed 
briefly in plain TBS. Finally, the blot was placed in a freshly prepared HRP substrate 
buffer (Table 4) for 5-45 minutes to develop at room temperature, rinsed briefly in 
ddH2O, and air-dried. 
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Table 4  Recipes for buffers and reagents used in Western blotting. 
Tris-Buffered Saline (TBS) 2X Stock, pH 7.5 (2 L) 
Tris 9.7 g 
NaCl 117 g 
ddH2O To 2 L 
Transfer Buffer, pH 8.3 
Tris 2.4 g/L 
Glycine 11.26 g/L 
Blocking Buffer 
Bovine Serum Albumin (BSA) 30 g 
1X TBS 1 L 
Wash Buffer 
Tween-20 0.5 mL 
1X TBS 1 L 
Substrate Buffer, pH 9.5 
Tris 6 g 
NaCl 2.9 g 
MgCl2 1 g 
ddH2O To 500 mL 
Horseradish Peroxidase (HRP) Substrate 
4-Chloronapthol 60 mg 
Methanol 20 mL 
30% H2O2 60 µL 
Substrate Buffer 100 mL 
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Analysis of Iron Transport in Variants 
 
Siderophore Nutrition Assays 
Siderophore nutrition assays were carried out using the method of Newton et al. 
(Newton et al. 1999). Commercially available (Sigma Co.) ferrichrome was used for 
these experiments. E. coli KDF541 with variant FhuA protein was grown to mid-
logarithmic phase in LB broth. A 3 mL quantity of nutrient soft agar was poured into 4 
cm petri dishes, with 0.2 mM dipyridyl to bind the free iron in the media, and 100 µl of 
the culture was added. A 10 µL quantity of a 50 µM solution of ferric siderophores was 
placed on filter disks on these plates. The plates were then incubated at 37°C for 24 
hours. Results were expressed as the area of visible growth around the filters. 
 
Binding and Transport Assays 
 In vivo concentration-dependent binding assays were carried out for both the wild 
type and variant FhuA using 55Fe-labeled ferrichrome. Bacterial seed cultures were 
grown in LB broth for 16 hours at 37°C and used as 1% inoculum for 50 ml of MOPS 
(Table 1) medium with 4% glycerol as a carbon source. Cells were grown in this 
medium for 4-6 hours at 37°C until OD 600= 0.4-0.6 and then induced with 0.1 mM of 
IPTG at 37˚C for 1.5 hours. The cells were then incubated on ice for 1 hour in order to 
drastically reduce cellular metabolism and then assayed at 0˚C for binding capacity 
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using increasing concentrations of radiolabeled ferrichrome, using time intervals of 1 
minute. All binding assays were performed in triplicate. 
In vivo concentration-dependent transport assays were conducted to determine 
the rate of transport, growing the wild type and variant FhuA in the same procedure as 
with the binding assays except without any incubation on ice. Transport assays were 
carried out at 37°C, measuring the rate of transpor t at increasing concentrations of 55Fe-
ferrichrome between 10 and 30 second intervals. The culture was maintained on a 
shaker at 37°C while aliquots were drawn to measure  transport at various 
concentrations. In vivo time-dependent transport assays were performed at 37˚C by 
measuring the amount of 55Fe-ferrichrome transported at the end of time intervals 
ranging from 15 seconds to 15 minutes, using 1 nM labeled ferrichrome. Cellular 
radioactivity was measured in 10 mL ScintaVerse scintillation fluid using a 1-minute 
count in a Wallac 1409 Liquid Scintillation Counter. All concentration-dependent and 
time-dependent transport experiments were performed in triplicate.  
 
Overexpression and Purification 
  
Extraction 
 The variant protein 104/149C was over-expressed by cloning the open reading 
frame of the mutant genes of FhuA in pET21b vector under T7 promoter, and 
transformed into E. coli. A 6L culture was grown overnight at 37˚C from a 1% inoculum 
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and pelleted at 8000 x g. The pellets were resuspended in FhuA Extraction Buffer A 
(Table 5) with 2% benzamidine as a protease inhibitor and the cells were crushed in a 
French press at 35,000 psi. The French Press used for the extraction of FhuA 104/149C 
was provided by Dr. Yue Zou of the Biochemistry and Molecular Biology Department at 
the James H. Quillen College of Medicine. The ultracentrifuge in Equipment Room A107 
of the James H. Quillen College of Medicine Biochemistry Department was used to spin 
the samples.  The lysate was centrifuged at 8000 x g for 10 minutes at 4˚C, the pellet 
(P1) was discarded, and the supernatant (S1) was harvested and centrifuged in an 
ultracentrifuge at 104,000 x g for 90 minutes at 4˚C. The supernatant was discarded 
and the pellet was resuspended in lysis buffer and centrifuged for 90 minutes at 
104,000 x g (B1). The previous step was repeated with an additional round of lysis 
buffer (B2). Next, the supernatant was again discarded, and the pellet was washed with 
distilled water (dH2O) and spun for an additional 90-minute cycle at 104,000 x g and the 
supernatant (S2) was discarded. The pellet (P2) was homogenized in FhuA Extraction 
Buffer B (Table 5) with 1% octylglucoside and incubated at room temperature for 30 
minutes on a rotary shaker. Then, it was centrifuged for 90 minutes at 104,000 x g. The 
supernatant was collected and the pellet was again homogenized in extraction buffer 
and spun for 90 minutes at 104,000 x g. The procedure was repeated and the second 
supernatant was collected and added to the previous and refrigerated overnight at 4°C. 
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Purification via HPLC 
 Protein was purified using a BioRad Biologic Duoflow HPLC system with a 
Waters 7.8 mm x 120 mm column as the stationary phase and deaerated, filtered low-
salt Tris-Benzamidine anion exchange buffer and high-salt anion exchange buffer as 
mobile phases (Table 5). These were filtered using a Millipore filtration system with 0.45 
µm membranes. The UV detector was set at 280 nm. The column was equilibriated with 
low-salt anion exchange buffer for 30 minutes prior to use. Sample volumes of 1 mL 
each were injected into the column. The program FhuA01.1 was used to elute the 
variant protein from the column. Fractions were tested for protein content using SDS-
PAGE and Western blot. After the entire sample had been purified, any fraction 
containing pure variant FhuA was pooled and concentrated using a Centricon 
concentrator. SDS-PAGE was used to verify the presence of pure protein in 1 ml 
fractions. 
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Table 5  Formulas for buffers used in the extraction and purification of FhuA 104/149C 
FhuA Extraction Buffer A (1 L), pH 8.0 
Tris 6.055 g 
Benzamidine 1.566 g 
ddH2O To 1 L 
FhuA Extraction Buffer B (100 mL), pH 8.0 
Tris 0.605 g 
Benzamidine 0.156 g 
Octyl-Glucoside 1 g 
ddH2O To 100 mL 
FhuA Anion Exchange Buffer (4 L), pH 7.5 
Tris 24.2 g 
Benzamidine 6.26 g 
Sodium Azide 0.78 g 
EDTA 2.92 g 
Triton X 80 mL 
NaCl (High Salt Buffer Only) 29.2 g 
ddH2O To 4 L 
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Table 6  FhuA01.1 HPLC program for purification of FhuA protein 
Step Number Start (mL) Step 
1 0.0 Isocratic flow with 100% 
low-salt buffer at 1.5 
mL/min 
2 6.0 UV Zero Baseline 
3 6.0 Isocratic flow with 100% 
low-salt buffer at 1.5 
mL/min 
4 16.0 Linear Gradient with 0%-
100% high-salt buffer at 1.5 
mL/min 
5 42.0 Isocratic flow with 100% 
high-salt buffer at 1.5 
mL/min 
6 45.9 Isocratic flow with 100% 
low-salt buffer at 1.5 
mL/min 
7 52.4 End run 
 
 
Data Analysis 
The radioactivity in the samples gathered in the binding and transport assays 
was measured in terms of CPM. These readings were converted to DPM considering 
the efficiency of the scintillation counter. Binding capacity, KD, KM, and VMax values were 
calculated using either the graphical plot or the GRAFIT 3.0 program from Erithacus. 
Binding and transport were measured and plotted against concentration and transport 
was measured and plotted against time in graphical presentations. 
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CHAPTER 3 
RESULTS 
 
Mutagenesis and Expression 
 Two single mutants and one tetra-cysteine mutant were created for this study. 
The basic, polar arginine 452 of FhuA was mutated both to neutral nonpolar alanine and 
neutral yet polar glutamine. Mutation to neutral polar glutamine will not allow salt bridge 
formation at that site within the protein but may allow hydrogen bond formation during 
transport of the ligand. Mutation to neutral nonpolar alanine will prevent hydrogen bond 
formation at that site (Chakraborty et al. 2006). Primers were designed using the fhuA 
sequence (Fig. 9). Based on previous data from the FatA iron transport protein (Lopez 
et al. 2007), R452 was expected to be involved in the transport process in FhuA but not 
in ligand binding.  
Four additional primers were designed to mutate the residues at locations 72, 
109, 356, and 615 to cysteine. The amino acids mutated in the tetra-cysteine variant 
were nonconserved amino acids whose mutation should not affect the function of FhuA 
protein. Creating a variant with four simultaneous mutations is difficult; previous 
attempts showed successful mutations in only two or three of the target codons. Two 
attempts were required in this study to create the tetra-cysteine mutant. Sequence data 
confirmed that all target codons in all three mutants were successfully changed via 
mutagenesis. The open reading frame of FhuA was then digested from pAlter plasmid 
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using EcoRI and Hind III, cloned into pUC18 plasmid, and transformed into E. coli iron 
transporter knockout strain KDF541. 
 SDS-PAGE and Western blot of each variant displayed clear bands at 
approximately 80 kDa, indicating that each mutant is expressing at a rate similar to the 
Wild Type (Fig. 10). 
 
 
 
FhuA   CC CTA GGC GGT CGT TAT GAC TGG GC 
R452A CC CTA GGC GGT GCT TAT GAC TGG GC 
R452Q CC CTA GGC GGT CAA TAT GAC TGG GC 
 
Figure 9  FhuA sequence aligned with R452A and R452Q sequences. The target codon 
is highlighted in all three sequences. 
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100 kDa 
75 kDa 
 
 
 
 
 
Figure 10  A Western Blot showing expression of FhuA variants: 1. 72/615/109/356C, 2. 
R452A, 3. R452Q, and 4. 104/149C. Protein expression was induced with IPTG for 3 
hours prior to sample preparation and loading into SDS-PAGE. The pink band of the 
kaleidoscope marker indicates 75 kDa. Wild type not shown. 
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Siderophore Nutrition Assays 
 Siderophore nutrition assays were carried out for variants R452A, R452Q, and 
72/615/109/356C as a rapid, inexpensive method of detecting deficiencies in 
ferrichrome transport (Table 7). After overnight incubation, a large zone of cell growth 
could be seen around the ferrichrome disk on the plate inoculated with 
72/615/109/356C. This result was similar to that of the wild type FhuA, which was used 
as a control, and indicates that the tetra-cysteine mutant was transporting 
ferricsiderophores in the media. No zone of growth could be found on the plate 
inoculated with R452A, and only a small zone of growth appeared on the plate 
inoculated with R452Q. This assay was carried out twice, and the results were 
consistent. 
Table 7  Results of the Siderophore Nutrition Assay for variants R452A, R452Q, and 
72/615/109/356C 
 
Variant Radius of the Zone of Cell Growth (mm) 
(Average of two experiments) 
Wild Type 22 
R452A 0 
R452Q 8 
72/615/109/356C 20 
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In vivo Binding and Transport Assays, the Lock Region 
 In vivo concentration-dependent binding assays were carried out for R452A, 
R452Q, E571A, E571Q, R93A, R133A, E522/571A, and E522/571Q to determine if any 
of these variants were defective in binding. All of the mutant FhuA proteins except 
R133A showed ligand binding similar to that of the wild type, increasing with ferrichrome 
concentration until they reached the point of saturation. R133A assay samples showed 
almost no radioactivity and therefore KD could not be determined (data not shown).  
E571A, E571Q, E522/571A, E522/571Q, R93A, R452A, and R452Q variants are fully 
capable of binding the ferricsiderophore complex (Fig. 11-14), while R133A 
concentration-dependent binding results indicate defective binding.  
Time-dependent transport assays were performed with 1 nM 55Ferrichrome with 
time intervals ranging from 30 seconds to 15 minutes in order to determine which 
variants were defective in transport. Time-dependent transport assays were performed 
first, because this is a much quicker and more cost-effective procedure than the 
concentration-dependent transport assay, in order to confirm transport capability. Any 
variant found to be transporting normally should then be assayed for KM and VMax using 
the concentration-dependent transport protocol. Data from these experiments revealed 
variably defective transport in mutants R452A and R452Q (Fig. 15). Data obtained 
previously also indicated that E571A, E571Q, E522/571A, E522/571Q, and R93A are 
defective in transport (Chakraborty et al. 2006).  
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Figure 11  Concentration-dependent Binding data for FhuA variant R93A. 
Concentrations of 55Ferrichrome ranged from 50 pM to 60 nM. Wild type data are 
included for comparison. Differences in binding capacity are likely due to variations in 
levels of FhuA expression. KD= 18.4 nM. 
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Figure 12  Concentration-dependent Binding data for FhuA variants E522/571A and 
E522/571Q. For E522/571A, KD= 1.0 nM. For E522/571A, KD= 5.0 nM. 
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Figure 13  Concentration-dependent Binding data for FhuA variants E571A and E571Q. 
For E571A, KD= 2.5 nM. For E571Q, KD= 7.5 nM. 
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Figure 14  Concentration-dependent Binding data for FhuA variants R452A and R452Q. 
For R452A, KD= 4.8 nM. For R452Q, KD= 2.5 nM. 
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Figure 15. Time-dependent transport data for FhuA variants R452A and R452Q; data 
for the FhuA WT and empty KDF541 cells are also included. This procedure is 
performed solely to assess whether or not a mutant is defective in transport. Both 
R452A and R452Q were determined to be defective. 
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In vivo Binding and Transport Assays of the Tetra-Cysteine Mutant 72/615/109/356C 
 Variant 72/615/109/356C was assayed for KD using the concentration-dependent 
binding procedure (Fig. 16); the tetra-cysteine mutant showed binding similar to the wild 
type, with increasing radioactive activity to the point of receptor saturation. A time-
dependent transport assay (Fig. 17) determined that 72/615/109/356C is also capable 
of transport at levels similar to the wild type. Therefore, a concentration-dependent 
binding assay was performed in order to determine KM and VMAX for this FhuA variant 
(Fig. 18). 
 
Figure 16  Concentration-dependent binding for FhuA variant 72/615/109/356C; KD= 9.1 
nM. 
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Figure 17  Time-dependent transport data for FhuA variant 72/615/109/356C. Data for 
FhuA WT and empty KDF541 cells are also included. Data indicate that this tetra-
cysteine mutant is capable of transport. 
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Figure 18  Concentration-dependent transport for FhuA variant 72/615/109/356C; 
KM=5.0 nM, VMAX=98. 
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KD, KM, and Vmax 
 Using data obtained from the concentration-dependent binding and 
concentration-dependent transport assays, KD and KM values were calculated for variant 
proteins using the Grafit 3.0 program to characterize binding and transport (Table 8). KD 
and KM were used to compare the binding affinity and transport, respectively, of variant 
FhuA to that of the wild type. KD was calculated from the data gathered from 
concentration-dependent binding assays. KM is defined as the substrate concentration 
that yields a half-maximal transport rate, or ½ VMax. VMax (Table 8) is the maximal 
velocity of the reaction at saturated substrate concentrations. KM and VMax were 
calculated from the concentration-dependent transport assay. 
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Table 8  KD, KM, and VMAX values for FhuA variants; KD values were determined from 
the curve generated by the concentration-dependent binding assay. KM and VMax were 
determined using data from the concentration-dependent transport assay. 
FhuA Mutants KD  
(nM) 
KM  
(nM) 
VMAX 
(pmoles/109 cells) 
Wild Type 0.5-5.0 0.1-1.0 50-150 
R93A 18.4 TDT indicates no transport 
R133A No 
binding 
Cannot be determined 
E571A 2.5 TDT indicates defective transport 
E571Q 7.5 TDT indicates defective transport 
E522/571A 1.0 TDT indicates defective transport 
E522/571Q 5.0 TDT indicates defective transport 
R452A 4.8 TDT indicates defective transport  
R452Q 2.5 TDT indicates defective transport 
72/615/109/356C 9.1 5.0 98 
TDT = Time-dependent Transport 
 
 
Extraction and Purification of 104/149C 
 FhuA variant 104/149C is a double-cysteine mutant created to assess whether or 
not the plug changes conformation within the β-barrel to form a channel during 
ferrichrome transport. As previously discussed, a disulfide bond connecting the β4 and 
β6 strands of the plug to prevent it from unfolding. Binding and transport data previously 
collected by Ms. Erin Storey indicated that 104/149C binds normally but is defective in 
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transport. As the final step in the characterization of the mutant, it should be purified and 
crystallized in order to observe structural changes. 
SDS-PAGE and Western blot performed after the extraction process (Fig. 19) 
showed the presence of FhuA in Supernatant 2 (S2) and Pellet 2 (P2). P2 was 
homogenized in Extraction Buffer containing 1% Octylglucoside, which has been shown 
to elute FhuA protein. A total of 40 ml supernatant was collected from the extraction 
process. The resulting solution was purified via HPLC. A total of three HPLC runs were 
performed to purify the entire sample, with 53 1 ml fractions collected per run. SDS-
PAGE of every fourth fraction showed small amounts of protein measuring at 
approximately 80 kDA in fractions 25-49. Unfortunately, due to the interference of 
Triton-X in the buffer, a graph of the protein peaks at OD280 could not be obtained.  
 Samples were taken in 50 µL quantities from various fractions and loaded onto 
SDS-PAGE gels to verify the presence of pure protein. Large quantities of FhuA protein 
were observed in fractions 30-33 from each run, although they were not entirely purified. 
These fractions were combined and dialyzed overnight to remove salt from the buffer. 
Then, they were injected into the HPLC column again to remove additional proteins. 
SDS-PAGE confirmed that the second round of HPLC yielded pure FhuA protein. 
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Figure 19. Western Blot of various samples taken during the process of extracting FhuA 
variant 104/149C. Lane 1. BioRad Broad Range Kaleidoscope protein markers; 2. Lysis 
Buffer Supernatant 2; 3. Supernatant 2; 4. Pellet 2. 
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CHAPTER 4 
 
DISCUSSION 
 
Ferrichrome transport was first studied to determine its role in microbial 
metabolism. In 1975, it was shown that tonA (now called fhuA) mutants resistant to 
phage T5 do not transport 55ferrichrome and that ferrichrome inhibits the lethal action of 
colicin M. Purified FhuA from the outer membrane had previously been shown to bind 
T5 and colicin M (Braun 2004 and references therein), so ferrichrome transport was 
linked to the fhuA gene. FhuA became a model for the elucidation of active, energy-
consuming transport across the outer membrane of Gram negative cells, especially in 
E. coli K-12 (Braun and Braun 2002).  
As previously discussed, FhuA transports ferrichrome, the structurally similar 
antibiotic albomycin, the structurally unrelated antibiotic rifamycin CGP 4832 (a 
derivative of rifamycin) and acts as a receptor for phages T1, T5, Ф80, and UC-1, and 
for colicin M (a toxic protein) and microcin J25 (a toxic peptide) (van der Helm 2004). All 
functions except for phage T5 infection require TonB activity. Comparison of the solved 
structures of ligand-bound and unbound FhuA reveals major conformational changes 
that take place after ferrichrome binds to the protein. The switch helix (residues 24-29) 
unwinds and residues E19, S20, and W22 shift 17 Å from their original α-carbon 
position (Braun and Braun 2002). This movement exposes the TonB box to the 
periplasm. 
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All variant FhuA proteins demonstrated normal expression as detected by SDS-
PAGE and Western blot, indicating that none of the mutations have deleterious effects 
on the expression of FhuA. Western blots were also performed on samples taken from 
each of the binding and transport assays to confirm expression of the target protein. All 
of these samples were positive for variant FhuA expression. 
Mutants E571A, E571Q, R93A, E522/571A, E522/571Q, and R133A were all 
created previously (Chakraborty et al. 2006). Time-dependent transport analysis was 
performed on these mutants by Erin Storey and they were determined to be defective in 
transport to varying degrees. It was necessary to analyze the binding capabilities of 
these mutants in order to determine whether the lack of transport in each variant was 
due to the involvement of the target amino acid(s) in the transport process, or if the 
particular mutation had rendered the variant protein unable to bind the siderophore, in 
which case the effects on transport cannot be determined. The results of the binding 
and transport assays suggest that the residues E571, E522, and R93 may play critical 
roles in the transport function of FhuA but not in binding (Table 8). E571, E522, R133, 
and R93 are all part of the highly conserved lock region and may be part of the transport 
process of FhuA but not involved in binding. R93 and R133 from the plug make up the 
quadrupole which forms hydrogen bonds and electrostatic interactions with E522 and 
E571 on strands 14 and 16 in the barrel. It is possible that the mutation of R133 to 
nonpolar alanine changed the structure of the protein in a way that made it unable to 
bind the ferricsiderophore complex. A previously created mutant, R133Q, showed 
binding similar to the Wild Type and was defective in transport (Chakraborty et al. 
2006). However, while glutamine is neutral like alanine, it is also polar like arginine and 
70 
 
therefore capable of forming hydrogen bonds. Mutation of the amino acid at location 
133 from a polar to a nonpolar residue may have a drastic effect on the structural 
integrity of the FhuA protein.  
The time-dependent transport data demonstrates that R452A and R452Q are 
indeed defective in transport, a conclusion that is further supported by the data obtained 
from the corresponding arginine in FatA, an outer membrane ferricsiderophore transport 
protein in Vibrio anguillarum (Lopez et al. 2007). It is thought that R452 is one of the 
residues lining the putative channel through which the ferricsiderophore passes, and 
that because of its positive charge and polarity, it induces the negatively charged 
ferricsiderophore complex to move from the binding site into the periplasm. It is not well 
understood whether the charge of the residue is the sole factor influencing its role in 
transport, or whether this is due to a combination of charge and its ability to form 
hydrogen bonds. To determine this, R452 was mutated to both alanine, a neutral 
nonpolar residue, and glutamine, a neutral polar residue.  
In spite of the differences in polarity between alanine and glutamine, the degree 
of defective transport is largely similar in both variants. They transport similar levels of 
55Ferrichrome to the Wild Type until around the 2 minute time interval, when transport 
reaches a plateau (Fig. 15). It is possible that these variants are able to transport a 
small amount of ferricsiderophore initially because the channel is still able to open upon 
binding of ferrichrome, but due to structural changes caused by the mutation, the 
protein is unable to return to its original configuration. Crystallization of R452A and 
R452Q will be required to fully assess this. Transport in KDF541 cells was measured for 
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use as a baseline for these experiments. E. coli KDF541 is a knockout strain that was 
developed with all known outer membrane ferricsiderophore receptors removed. The 
minimal level of transport in KDF541 cells lacking FhuA genes is likely due to diffusion, 
although it could also be attributed to an as yet undiscovered iron transport mechanism. 
Minimal transport was seen in R452Q in the nutrition assay; this may be because polar 
glutamine continues to form hydrogen bonds that could contribute to a lesser degree of 
defective transport, while nonpolar alanine does not. 
By selecting one amino acid in the β-barrel and a nearby amino acid in the plug 
domain and mutating them both to cysteine, a strong disulfide bond can be created to 
tether the plug to the inside of the barrel. Two double-cysteine mutants, 72/615C and 
74/587C, were previously created to ascertain whether the plug domain is expelled 
during transport, or if it changes conformation to create a channel. The mutant 74/587C 
was able to bind ferrichrome; however, transport was significantly reduced. It was later 
determined that P74 is conserved in FhuA and may be involved in positioning the 
ferrichrome binding loop A (Eisenhauer et al. 2005; van der Helm and Chakraborty 
2002). Variant 72/615C demonstrated normal binding and transport with regard to the 
Wild Type, with comparable KD and KM (17.2 nM and 0.3 nM, respectively). These 
results are corroborated by the data obtained by Eisenhauer et al. in 2005 using 
ferricrocin transport with FhuA. These results indicate that the plug may not need to be 
completely removed from the barrel in order for transport to take place. However, it 
could not be determined whether the plug was actually unfolding or if it was merely 
being pushed aside during transport.  
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The tetra-cysteine mutant 72/615/109/356C was made to tether the plug to the 
barrel on two sides so that it could not be displaced by the ligand during transport. 
Copper sulfate, an oxidizing reagent, was added to the media in which this mutant was 
grown to ensure that the disulfide bonds would not be reduced.  In creating the tetra-
cysteine mutant, it was necessary to choose nonconserved residues for mutagenesis. If 
conserved residues were used, it would be impossible to ascertain whether the resulting 
variant FhuA was defective in transport due to the plug being tethered in place, or due 
to a structural change in the protein that made it unable to carry out transport 
regardless. Great care was also taken to ensure that the target amino acids were 
located far from the TonB box, so that their mutation would not affect energy 
transduction.  Time-dependent transport data for 72/615/109/356C indicates that the 
tetra-cysteine mutant transports the ligand normally with respect to the Wild Type. 
These results are largely corroborated by the results of the siderophore nutrition assays. 
FhuA mutant 72/615/109/356C is able to bind the ferricsiderophore and transport it into 
the cell. Thus, tethering the plug domain in place inside the β-barrel does not appear to 
diminish transport of the ligand. This supports the hypothesis that the plug unfolds 
within the barrel to form a channel during transport.  
The double-cysteine mutant 104/149C was created in order to determine whether 
the core of the plug domain underwent conformational changes involving the movement 
of β-strands 4 and 6. Amino acids N104 and L149 were mutated so that they would form 
a disulfide bond tying these two strands together. Variant 104/149C demonstrated 
normal binding but defective transport, supporting the hypothesis that transport of the 
ligand requires partial disassembly of the core beta sheet of the plug. This supports the 
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formation of a channel rather than the expulsion of the plug during ligand transport. It is 
likely that only a partial disassembly is required because when the turn after β-strand 4 
or the continuation of this strand is tethered to the barrel with a disulfide bond, the 
protein is still capable of normal transport (Eisenhauer et al. 2005). This variant was 
purified for crystallization in order to determine what structural changes may have been 
caused by the mutations, so that a better understanding of the transport process may 
be gained.   
The other FhuA variants used in this study should also be crystallized as the final 
step in their characterization. Crystallization of the lock region mutants may lead to a 
better understanding of how their mutation has impacted their role in transport. 
Likewise, with the two R452 variants, having a three-dimensional image of the protein 
will better elucidate the relationships between this amino acid’s charge and polarity and 
its possible interactions with the ferricsiderophore as it moves through the putative FhuA 
channel. It would be especially interesting to see these proteins crystallized in ligand-
bound form as well.  
The tetra-cysteine mutant 72/615/109/356C should also be crystallized. This 
should confirm the presence of disulfide bonds that tether the plug domain in place, 
while also providing insight into any minor structural changes. Additionally, 
crystallization of the ligand-bound form would likely yield further data to support the 
hypothesis that the plug domain of FhuA unfolds to form a channel during transport. 
There is also another tetra-cysteine mutant, 72/615/112/383C, which was created for 
this study; however, its expression has not been confirmed and it has not been the 
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subject of any further analysis. Characterization of this mutant would be beneficial to 
provide further corroboration for our hypothesis regarding conformational changes in the 
plug domain during ligand transport. 
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